Insights and lessons learned from a prospective clinical pharmacology study in allogeneic hematopoietic stem cell transplant during the COVID-19 pandemic

Clin Transl Sci. 2022 Mar;15(3):583-587. doi: 10.1111/cts.13177. Epub 2021 Nov 7.
No abstract available

MeSH terms

  • COVID-19*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Pandemics
  • Pharmacology, Clinical*
  • Prospective Studies